Cancer leading cause of death among people with diabetes

February 04, 2021

This is the finding of an 18-year-study of over 300,000 people with diabetes in England, from scientists from Imperial College London and published in the journal The Lancet Diabetes & Endocrinology.

Thursday Feb 4th is World Cancer Day.

The research, funded by the Wellcome Trust, reveals that between 2001-2018 heart disease and stroke were no longer the leading causes of death among people with diabetes, as they were 18 years ago.

Diabetes affects 4.7 million people in the UK, and is caused by the body being unable to regulate blood sugar levels. Around 90 per cent have type 2 diabetes, which is associated with lifestyle factors such as high blood pressure and excess weight.

The remainder have type 1 diabetes, which is caused by the body attacking the cells that produce insulin, the hormone that controls blood sugar.

In the study, researchers from Imperial's School of Public Health looked at anonymised primary care data from 313,907 people in England with diabetes between 2001-2018, and linked this with death data from the Office of National Statistics.

The study revealed death rates for those with diabetes declined in the study period by 32 per cent for men, and 31 per cent for women.

The team explain deaths from heart disease and stroke have reduced across the whole population, including those without diabetes.

Dr Jonathan Pearson-Stuttard, lead author of the study, said: "Improvements in risk factors such as smoking and blood pressure, along with progress in medical treatments have contributed to large falls in deaths from heart disease and stroke. The improvements have been even greater in those with diabetes. This has resulted in vascular conditions accounting for around 25 per cent of all deaths in those with diabetes compared to 45 per cent 20 years ago.

"In contrast, improvements in cancer death rates have been much more modest, with improvements in those with diabetes lagging behind the general population. It is striking that cancer is now the leading cause of death in England among people with diabetes and the leading contributor to excess death compared to those without diabetes. Added to this is the fact the UK continues to lag behind other EU countries in terms of cancer survival rates."

The findings also showed people with diabetes were more likely to die from dementia, liver disease, or respiratory disease in 2018 than people without diabetes.

Death rates were higher in those with diabetes compared to those without in almost all causes studied. Death rates for liver disease and dementia were twice as high in those with diabetes compared to those without in 2018, while respiratory death rates were 80 per cent higher.

he research team say individuals with diabetes have up to a two-fold increased risk of dementia compared with those without diabetes. The precise link for this is unclear but there are several shared risk factors such as smoking, obesity and poor diet between diabetes and dementia.

The increase in liver disease could be due to the high levels of obesity among people with diabetes, and a higher alcohol consumption.

The team call for guidance around the treatment of diabetes to be updated, to ensure patients and clinicians are aware of the breadth of conditions they are at higher risk of including cancer, dementia and liver disease.

They add that the reasons for cancer being the leading cause of death are unclear, but could be linked to the fact people with diabetes are more likely to be overweight, and excess weight is a leading risk factor for cancer.

The team also highlight limitations of the study, such as the inability to differentiate between type one and two diabetes in the data, and the fact around 20 per cent of people with diabetes in the UK are undiagnosed.

Professor Edward Gregg, senior author of the study added: "This study is another reminder that as people die less from cardiovascular diseases, diabetes still leads to a wide range of other problems. The diversification of the big contributors to death here included cancers, dementia and respiratory diseases. This, and the current experience with COVID-19, is a reminder that we need to take an increasingly broad view about what prevention means for people with diabetes."
-end-


Imperial College London

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.